Armata Pharmaceuticals, Inc. Annual Operating Lease, Payments in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Armata Pharmaceuticals, Inc. quarterly/annual Operating Lease, Payments history and growth rate from 2019 to 2023.
  • Armata Pharmaceuticals, Inc. Operating Lease, Payments for the quarter ending March 31, 2024 was $3.36M, a 35.4% decline year-over-year.
  • Armata Pharmaceuticals, Inc. annual Operating Lease, Payments for 2023 was $3.5M, a 29.6% increase from 2022.
  • Armata Pharmaceuticals, Inc. annual Operating Lease, Payments for 2022 was $2.7M, a 22.7% increase from 2021.
  • Armata Pharmaceuticals, Inc. annual Operating Lease, Payments for 2021 was $2.2M, a 100% increase from 2020.
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $3.5M +$800K +29.6% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-21
2022 $2.7M +$500K +22.7% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-21
2021 $2.2M +$1.1M +100% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-16
2020 $1.1M -$600K -35.3% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-17
2019 $1.7M Jan 1, 2019 Dec 31, 2019 10-K 2021-03-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.